China sees huge bounce in pharma rankings ahead of hybrid CPhI & P-MEC China |
November 18, 2021 | November 2021 Bond Updates |
SHANGHAI, Nov. 18, 2021 /PRNewswire/ -- China's pharma industry has seen a record improvement in its overall score, growth potential and biologics according to new data. The China specific findings of the CPhI Annual Report rankings[1] are released ahead of CPhI & P-MEC China - which will... |
View more at: https://www.prnewswire.com:443/news-releases/china-sees-huge-bounce-in-pharma-rankings-ahead-of-hybrid-cphi--p-mec-china-301427450.html |
Related News |